Spots Global Cancer Trial Database for mebendazole
Every month we try and update this database with for mebendazole cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Mebendazole as Adjuvant Treatment for Colon Cancer | NCT03925662 | Colorectal Canc... | Folfox with ava... Mebendazole | 18 Years - | Tanta University | |
A Phase I Study of Mebendazole for the Treatment of Pediatric Gliomas | NCT01837862 | Pilomyxoid Astr... Pilocytic Astro... Glioma, Astrocy... Optic Nerve Gli... Pleomorphic Xan... Glioblastoma Mu... Anaplastic Astr... Gliosarcoma Diffuse Intrins... DIPG Low-grade Gliom... Brainstem Gliom... | Mebendazole Vincristine Carboplatin Temozolomide Bevacizumab Irinotecan | 1 Year - 21 Years | Northwell Health | |
To Study the Effects of Addition of Mebendazole to Lenvatinib in Cirrhotics With Advanced Hepatocellular Carcinoma. | NCT04443049 | Hepatocellular ... Liver Cirrhosis | Lenvatinib Mebendazole Placebo | 18 Years - 70 Years | Institute of Liver and Biliary Sciences, India | |
Phase I Study of Mebendazole Therapy for Recurrent/Progressive Pediatric Brain Tumors | NCT02644291 | Medulloblastoma Astrocytoma, Gr... Glioblastoma Anaplastic Astr... Brain Stem Neop... Oligodendroblas... Anaplastic Olig... Malignant Gliom... | Mebendazole | 1 Year - 21 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
Study of the Safety, Tolerability and Efficacy of Metabolic Combination Treatments on Cancer | NCT02201381 | Cancer Overall Surviva... | Metabolic treat... | 18 Years - 85 Years | Health Clinics Limited | |
To Study the Effects of Addition of Mebendazole to Lenvatinib in Cirrhotics With Advanced Hepatocellular Carcinoma. | NCT04443049 | Hepatocellular ... Liver Cirrhosis | Lenvatinib Mebendazole Placebo | 18 Years - 70 Years | Institute of Liver and Biliary Sciences, India | |
Study of the Safety, Tolerability and Efficacy of Metabolic Combination Treatments on Cancer | NCT02201381 | Cancer Overall Surviva... | Metabolic treat... | 18 Years - 85 Years | Health Clinics Limited | |
Study of the Safety, Tolerability and Efficacy of Metabolic Combination Treatments on Cancer | NCT02201381 | Cancer Overall Surviva... | Metabolic treat... | 18 Years - 85 Years | Health Clinics Limited |